Cargando…
A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma
SIMPLE SUMMARY: Decision about treatment choice in early-stage colon cancer may be difficult for clinicians because of a lack of published data. Colon cancer is a very heterogeneous disease, but some previous efforts have helped us elucidate potential biomarkers for characterizing patients. Our goal...
Autores principales: | Azcue, Pablo, Guerrero Setas, David, Encío, Ignacio, Ibáñez-Beroiz, Berta, Mercado, María, Vera, Ruth, Gómez-Dorronsoro, María Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656725/ https://www.ncbi.nlm.nih.gov/pubmed/34885019 http://dx.doi.org/10.3390/cancers13235909 |
Ejemplares similares
-
PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification
por: Azcue, Pablo, et al.
Publicado: (2021) -
Comorbidity and prognostic indices do not improve the 5-year mortality prediction of components of comprehensive geriatric assessment in hospitalized older patients
por: Martínez-Velilla, Nicolás, et al.
Publicado: (2014) -
EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas
por: Perez-Janices, Noemi, et al.
Publicado: (2015) -
Shared component modelling as an alternative to assess geographical variations in medical practice: gender inequalities in hospital admissions for chronic diseases
por: Ibáñez-Beroiz, Berta, et al.
Publicado: (2011) -
Effect of Physical Activity on Cardiovascular Event Risk in a Population-Based Cohort of Patients with Type 2 Diabetes
por: Enguita-Germán, Mónica, et al.
Publicado: (2021)